NDC 68788-7149

Doxazosin

Doxazosin

Doxazosin is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Preferred Pharmaceuticals Inc.. The primary component is Doxazosin Mesylate.

Product ID68788-7149_05179a65-55c3-492f-a5c0-1751467e8aac
NDC68788-7149
Product TypeHuman Prescription Drug
Proprietary NameDoxazosin
Generic NameDoxazosin
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2018-04-23
Marketing CategoryANDA / ANDA
Application NumberANDA202824
Labeler NamePreferred Pharmaceuticals Inc.
Substance NameDOXAZOSIN MESYLATE
Active Ingredient Strength4 mg/1
Pharm ClassesAdrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 68788-7149-3

30 TABLET in 1 BOTTLE (68788-7149-3)
Marketing Start Date2018-04-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68788-7149-9 [68788714909]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA202824
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-04-23

NDC 68788-7149-3 [68788714903]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA202824
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-04-23

NDC 68788-7149-6 [68788714906]

Doxazosin TABLET
Marketing CategoryANDA
Application NumberANDA202824
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-04-23

Drug Details

Active Ingredients

IngredientStrength
DOXAZOSIN MESYLATE4 mg/1

OpenFDA Data

SPL SET ID:3104e41f-2d01-4db4-98ba-5a3f69d54733
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197627

    • Pharmacological Class

    • Adrenergic alpha-Antagonists [MoA]
    • alpha-Adrenergic Blocker [EPC]

    NDC Crossover Matching brand name "Doxazosin" or generic name "Doxazosin"

    NDCBrand NameGeneric Name
    0093-2067DoxazosinDoxazosin Mesylate
    0093-2068DoxazosinDoxazosin Mesylate
    0093-2069DoxazosinDoxazosin Mesylate
    0093-2070DoxazosinDoxazosin Mesylate
    0378-4021Doxazosindoxazosin mesylate
    0378-4022Doxazosindoxazosin mesylate
    0378-4024Doxazosindoxazosin mesylate
    0378-4028Doxazosindoxazosin mesylate
    0615-5536DoxazosinDoxazosin mesylate
    0615-5537DoxazosinDoxazosin mesylate
    0615-6570DoxazosinDoxazosin mesylate
    0615-6571DoxazosinDoxazosin mesylate
    0832-0356DoxazosinDoxazosin Mesylate
    0832-0357DoxazosinDoxazosin Mesylate
    0832-1358DoxazosinDoxazosin Mesylate
    0832-1359DoxazosinDoxazosin Mesylate
    68071-1889DoxazosinDoxazosin
    68071-4273DoxazosinDoxazosin
    68071-3298DoxazosinDoxazosin
    68071-3331DoxazosinDoxazosin
    68071-3341DoxazosinDoxazosin
    68071-4272DoxazosinDoxazosin
    68084-862DoxazosinDoxazosin
    68084-836DoxazosinDoxazosin
    68084-851DoxazosinDoxazosin
    68382-783DoxazosinDoxazosin
    68382-785DoxazosinDoxazosin
    68382-784DoxazosinDoxazosin
    68382-786DoxazosinDoxazosin
    68645-464DoxazosinDoxazosin
    68645-465DoxazosinDoxazosin
    68645-463DoxazosinDoxazosin
    68788-7149DoxazosinDoxazosin
    68788-7328DoxazosinDoxazosin
    68788-9675DoxazosinDoxazosin
    70518-0839DoxazosinDoxazosin
    70518-1061DoxazosinDoxazosin
    70518-1645DoxazosinDoxazosin
    70518-1560DoxazosinDoxazosin
    70518-1804DoxazosinDoxazosin
    70771-1115DoxazosinDoxazosin
    70771-1114DoxazosinDoxazosin
    70771-1112DoxazosinDoxazosin
    70771-1113DoxazosinDoxazosin
    71335-0309DoxazosinDoxazosin
    71335-0349DoxazosinDoxazosin
    71335-0002DoxazosinDoxazosin
    71610-153DoxazosinDoxazosin
    71610-160DoxazosinDoxazosin
    71610-043DoxazosinDoxazosin
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.